Ukulinganisa Izingozi Nezinzuzo
Iziguli ze-arthritis ngezinye izikhathi ziyesaba izinto eziphilayo , ezaziwa nangokuthi i-biologic response modifiers. Izidakamizwa zokuqala ze-biologic ezamukelwa yi-FDA ngezinhlobo ezivuthayo zamarthritis zaziyizidakamizwa eziphikisana ne-TNF , ezivame ukubizwa ngokuthi i-TNF (tumor necrosis inhibitor). Kunemiphumela emibi engase ibe yinkinga ehambisana ne-TNF blockers, njenge-infection ejulile ne-lymphoma, ngakho-ke ezinye izimo zesaba akuzona ezingenangqondo.
Kodwa, akufanele yini ukukala izingozi nezinzuzo zokwelashwa nge-block block ye-TNF?
I-TNF blockers, ebizwa ngokuthi i-DMARD ye-biologic, ihlanganisa i- Enbrel (etanercept), i- Humira (adalimumab), i- Remicade (infliximab), i- Simponi (golimumab), ne- Cimzia (certolizumab pegol). Unesilinganiso esihle kakhulu senzuzo / engozini. Ngamanye amazwi, ngenkathi imiphumela emibi ingase ikhule, ayivamile. Kuyaphawuleka ukuthi iziguli eziningi zithola ukuthuthukiswa okuphawulekayo kokuthatha izidakamizwa.
Izibalo ze-TNF ziye zacwaningwa ngeziguli iminyaka eminingi futhi sezilokhu zithengiswa emakethe kusukela ngo-1998. Ukukhathazeka okukhulu kulezi zidakamizwa kufaka ingozi yokutheleleka okuthelelekile noma i-lymphoma. Ngisho nangaphandle kokuthatha i-TNF blockers, iziguli zesifo se-rheumatoid isifo esiningi sokwenza lezi zinkinga ezimbili (ukutheleleka noma i-lymphoma) uma kuqhathaniswa nomphakathi jikelele. Eqinisweni, iziguli ezinezifo ezinzima kakhulu zesifo se-rheumatoid arthritis cishe zikwazi ukuthuthukisa i-lymphoma kunalabo abanezifo ezinzima.
Kukhona ubufakazi bokuthi izidakamizwa ze-biologic zandisa ingozi yokuthola izifo ezingavamile, ezifana nesifo sofuba (i-TB) . Ngakho-ke, kunconywa ukuthi zonke iziguli zihlolwe ngezivivinyo zesikhumba kanye ne-x-ray esifubeni ukuze zihlolwe ngaphambi kokuba kutholakale i-TB ngaphambi kokuqala ukwelapha nge-blocker ye-TNF.
Kufanele uqaphele ngokwengeziwe ngokuthatha ama-blockers we-TNF uma ushukela ngesifo sikashukela noma unezinye izizathu zokuba ubungozi bokutheleleka, ukutheleleka okuphindaphindiwe, noma amanxeba avulekile noma izilonda.
Iziguli eziningi ze-rheumatoid zingenza kahle kakhulu kwi- DMARD yendabuko, njenge- Plaquenil (i-hydroxychloroquine), i- Azulfidine (i-sulfasalazine) noma i- Rheumatrex (methotrexate) futhi angeke idingeke ithathe i-blocker ye-TNF. Ezigulini ezinezifo ezibalulekile futhi ezinezizathu ezingafanele zithathe imettretreate (isb., Isibindi sesibindi), ama-blockers we-TNF angasetshenziswa njengendlela yokwelapha lokuqala.
Okubalulekile
Uma unqunywe i-blocker ye-TNF futhi uyavuma ukuzama, khumbula:
- Yazi imiphumela emibi engaba khona ehlobene ne-block block ye-TNF.
- Qaphela. Qaphela izimpawu ezintsha ezingase zakhiwe ngemuva kokuqala ukuvimba kwe-TNF.
- Ungabeki phansi izimpawu ezintsha. Bika izinguquko kudokotela wakho futhi uvumele udokotela wakho anqume ukubaluleka nokuthi yini okufanele yenziwe.
- Nakuba ukuqaphela nokuqapha kubalulekile uma uqala noma imuphi umuthi omusha, futhi ikakhulukazi onemiphumela emibi engase ibe yingozi, khumbula ukuthi iningi imiphumela emibi noma ukusabela okubi akuvamile. Nciphisa ukwesaba kwakho ngeqiniso.
- Xoxa ngokukhathazeka kwakho nodokotela wakho. Hlola izinzuzo ezihambisana nezingozi zokwelapha nge-blocker ye-TNF. Cabanga ngobukhulu besimo sakho, izimo ezibucayi , nezinye izinketho zokwelapha. Kanye nodokotela wakho, uhlele uhlelo futhi uqonde imigomo yokwelashwa kanye nokuthi kuzoba yini inkambo yesenzo uma kukhona okungahambi kahle.
Umthombo:
Impendulo enikeziwe, ngokwengxenye, nguScott J. Zashin, MD uDkt. Zashin ungumprofesa wothisha osesithombeni eNyuvesi yaseTexas Southwestern Medical School kanye nodokotela ozofika esibhedlela samaPresbyterian aseDallas nasePlano. UDkt. Zashin ungumbhali we- Arthritis Ngaphandle kobuhlungu - Isimangaliso se-TNF Blockers nombhali-mbhali we- Natural Arthritis Treatment .